KEN Fin.Serv. (530547)
Asset PlayScore breakdown: P/E: 2/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹16.35 |
| Market Cap | ₹5.16 Cr |
| P/E Ratio | 14.64 |
| ROCE | 3.07% |
| ROE | 3.04% |
| Dividend Yield | 0% |
| Profit Growth | 0% |
| Debt/Equity | — |
| Sales Growth | 0% |
| 52-Week Range | ₹8.64 — ₹16.8 |
| Sector | Finance |
| Book Value | ₹23.82 |
Strengths
- Trades at P/B of 0.69, a 31% discount to book value of ₹23.82.
- P/E of 14.64 is moderate if trailing earnings are reliable.
- ROE and ROCE are positive at 3.04% and 3.07%, though low.
- Current price of ₹16.35 is well above the 52-week low of ₹8.64.
Concerns
- Latest quarter reported sales of ₹0 Cr and net profit of ₹0 Cr.
- Sales growth and profit growth are both 0.00%, with no dividend yield.
- Piotroski F-score of 4/9 indicates weak financial health.
- Debt/equity and promoter holding are not disclosed, limiting an outside investor's assessment.
AI Analysis
When I look at KEN Fin.Serv., I have to be honest with myself: this is not the kind of business that would keep me awake at night for good reasons. It is an NBFC, an industry I understand, but understanding does not mean enthusiasm. The market price is ₹16.35 and book value is ₹23.82, so the stock trades at a price-to-book of 0.69. That looks like a discount, and in Graham's language it gives some margin of safety. But a discount to book is only interesting if the book is solid and the business can generate earnings. Here, return on equity is just 3.04% and ROCE is 3.07%. Put simply, the company is earning very little on the capital tied up in the business. With sales growth and profit growth both at 0.00%, and no dividend, a patient shareholder is getting little in hand or in growth. The latest quarter shows sales of ₹0 Cr and net profit of ₹0 Cr, which is a red flag I cannot ignore. A financier with no revenue or profit in the latest quarter may be dormant, or the numbers may not reflect the true picture. The Piotroski F-score of 4 out of 9 also points to weak financial health. On the positive side, the price has held above its 52-week low of ₹8.64, and the P/E of 14.64 is not excessive. However, the market cap of only ₹5 Cr means it will always be a micro-cap, with limited institutional attention. Ultimately this looks more like an asset play than a growing enterprise. I would only consider it if an investigation of the loan book and asset quality confirms that the book value is real. Otherwise, a low price-to-book can be a value trap.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer